Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1009 of 3330
Next
>>
>
25201 to 25225 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	10999.156	1.0952	1.4044	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	10999.156	1.2213	1.9979	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	10999.156	0.9450	0.7838	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	10999.156	0.9490	0.7987	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.107	uM	10999.156	0.6669	-0.1193	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.533	uM	10999.156	0.7433	0.0970	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	2.67	uM	10999.156	0.6189	-0.2427	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	13.3	uM	10999.156	0.6153	-0.2517	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	66.7	uM	10999.156	0.3637	-0.7418	0.4940
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	12379.164	0.9635	0.8348	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	12379.164	0.9576	0.8092	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	12379.164	0.8729	0.4600	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	12379.164	0.8007	0.1954	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.107	uM	12379.164	0.6703	-0.2081	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.533	uM	12379.164	0.6443	-0.2773	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	2.67	uM	12379.164	0.5911	-0.4081	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	13.3	uM	12379.164	0.5899	-0.4108	0.4318
MDA-MB-361	HER2amp	Luminal	Everolimus	MTOR	MTOR	66.7	uM	12379.164	0.2956	-0.8811	0.4318
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	10938.156	1.0377	1.0834	0.9058
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	10938.156	0.9492	0.8882	0.9058
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	10938.156	1.0196	1.0433	0.9058
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	10938.156	0.8805	0.7379	0.9058
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	0.107	uM	10938.156	0.6022	0.1425	0.9058
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	0.533	uM	10938.156	0.6022	0.1426	0.9058
MDA-MB-415	HR+	Luminal	Everolimus	MTOR	MTOR	2.67	uM	10938.156	0.5977	0.1331	0.9058

|<
<<
Previous
Page 1009 of 3330
Next
>>
>
25201 to 25225 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)